Skip to main content
. 2023 May 11;19(9):2678–2694. doi: 10.7150/ijbs.81892

Table 1.

Summary of ferroptosis inducers and inhibitors

Classification Reagents Mechanism Reference
Ferroptosis Inducers Erastin Inhibition of system Xc- and VDAC2/3 10
Sulphasalazine Inhibition of system Xc- 10, 48
Sorafenib Inhibition of system Xc- and Nrf2 49, 50
Glutamate Inhibition of system Xc- and Cys deprivation 51
RSL3 GPX4 inactivation 32
Solasonine GPX4 inactivation 52
Altretamine GPX4 inactivation and promotion of ROS 53
FINO2 GPX4 inactivation and oxidation of unstable iron 54
FIN56 GPX4 inactivation and CoQ10 deletion 55
BSO GSH deletion 32
DPI2 GSH deletion 32
Cisplatin GSH deletion and GPX4 inactivation 56
Artesunate Degradation of ferritin and increased cellular iron 57
iFSP Inhibition of FSP1 34
Brequinar Inhibition of DHODH 36
Ferroptosis Inhibitors Ferrostatin-1 Inhibition of lipid peroxidation 58
Liproxstatin-1 Inhibition of lipid peroxidation 33
Necrostatin-1 Inhibition of lipid peroxidation 33, 59
SRS 16-86 Inhibition of lipid peroxidation 60
SRS 11-92 Inhibition of lipid peroxidation 58
Nuciferine Inhibition of lipid peroxidation 61
TEMPO Elimination of ROS 62
Phenothiazine Elimination of ROS 63
Phenoxazine Elimination of ROS 63
Diarylamine Elimination of ROS 63
Vitamin E Elimination of ROS and inactivation of LOXs 27, 64
NDGA Inactivation of LOXs 65
Zileuoton Inactivation of LOXs 66
Baicalein Inactivation of LOXs and ACSL4 65, 67
Thiazolidinedione Inactivation of ACSL4 68
Dexrazoxane Depletion of cellular iron 69
Deferoxamine Depletion of cellular iron 69
Deferiprone Depletion of cellular iron 70
β-Mercaptoethanol Increased cysteine intake 71
Vitamin K Activation of FSP1 72
Curcumin Activation of Nrf2 73
Quercetin Activation of Nrf2 and elimination of ROS 74, 75
MCTR1 Activation of Nrf2 76
Irisin Activation of Nrf2 77